首页> 中文期刊> 《中国临床保健杂志》 >胰岛素强化治疗对初诊断2型糖尿病患者胰岛功能的影响

胰岛素强化治疗对初诊断2型糖尿病患者胰岛功能的影响

         

摘要

目的了解短期胰岛素强化治疗对初诊断2型糖尿病患者胰岛α细胞及β细胞功能的影响。方法选取初诊断的2型糖尿病患者30例,对入选的患者给予胰岛素强化治疗(甘精胰岛素+三餐前速效人胰岛素类似物或胰岛素泵),治疗前后均行C肽释放试验(馒头餐试验),检测空腹、餐后半小时及餐后2h的胰高血糖素、C肽及静脉血糖值。结果与强化治疗前相比,患者各时点静脉血糖明显下降,强化治疗后HOMA-IR指数均有显著降低(P<0.05),而HOMA-β指数显著升高(P<0.05),C肽血糖净增比(△CP30/△G30,△CP120/△G120)均有上升(P<0.05),各时点CP/胰高血糖素比显著升高(P<0.05);结论胰岛素短期强化治疗对初诊断的2型糖尿病患者的β细胞及α细胞功能均有改善作用,并能部分改善胰岛素抵抗。%Objective To observe the changes of αand βislet cell function by short-term intensive insulin therapy in patients with newly diagnosed type 2 diabetes Mellitus (T2DM).Methods 30 patients with newly diag-nosed with T2DM were selected.The patients were allocated to receive intensive insulin therapy (insulin glargine and short-acting insulin analogues /insulin pump before each meal ) .C-peptide test ( steamed bread meal test ) was per-formed before and after treatment for all patients .The level of glucagon ,C-peptide and venous blood glucose were de-tected at the time of fasting,0.5h and 2 h after the meal.Results The levels of venous blood glucose at different time point and HOMA-IR were decreased after the intensive treatment (p<0.05),while the index of HOMA-βwere signif-icantly increased (p<0.05).The ratio of △CP30/△G30,△CP120/△G120 and CP/glucagon at each time point were increased (p<0.05),Conclusion Short-term intensive insulin therapy could improve the function of αandβislet cell in patients with newly diagnosed T 2DM.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号